This meeting will address the latest challenges and opportunities resulting from EMA, Health Canada and National Institutes of Health data disclosure & transparency policies, and gain insights on different approaches to navigate and comply with global disclosure and transparency requirements for medicinal products and medical devices.

Also discussed is the impact of the EU General Data Protection Regulation (GDPR) on data sharing; various strategies for preparing for the implementation of the EU Clinical Trials Regulation; the impact of Brexit on MHRA and disclosure requirements; how new ICMJE data sharing requirements are being implemented; what approaches sponsors are taking for redaction and anonymization; and updates on sponsor compliance.

Don’t miss your chance to connect with the decision makers and showcase your products and solutions to the right people!

CONNECT WITH...

• Regulatory affairs & Scientific affairs Heads / Officers / Directors / Managers / Specialists
• Medical Writing & Communication professionals
• Clinical Operations Specialists
• Biostatisticians/biometrics
• Medical Affairs professionals
• Consultants, CROs and companies that offer services for submitting to clinical trial registries, publication planning and medical writing

….and many more!

The Table Top Package comes with 1 Full Meeting Registration for only EUR 3000, so you will be able to enjoy the valuable insights that your chosen conference will have to offer.

Interested in exhibiting at DIA Clinical Trial Regulation Conference? Well exhibit at both events for only EUR 4000.

Exhibiting, Advertising and Hosting Opportunities Now Available

Request Further Information